Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.

Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
复制标题

DOI:
10.1007/s11904-020-00508-z
复制
发表时间:
2020-08
影响因子:
4.6
通讯作者:
Lo Re V 3rd
Lo Re V 3rd
中科院分区:
医学2区
文献类型:
--
作者:
Ferrante ND;Lo Re V 3rd

文献摘要

参考文献

被引文献

相似文献

关于HIV/B型肝炎病毒(HBV)合并感染者中丁型肝炎病毒(HDV)感染的患病率、决定因素和结局的数据有限。本文综述了HIV/HBV合并感染患者HDV感染的流行病学、自然史和治疗方面的最新证据,并强调了未来的研究需求。欧洲、非洲、南美洲和亚洲的横断面研究表明,HIV/HBV合并感染患者中HDV的患病率为1.2%-25%。目前还没有研究评估美国HIV/HBV合并感染患者中HDV感染的患病率。HDV感染增加了HIV/HBV合并感染患者肝失代偿和肝细胞癌的风险。HDV治疗仍然局限于聚乙二醇化干扰素-α,其导致<25%的持续病毒学应答。关于HIV/HBV合并感染者中HDV的流行病学、自然史和治疗的数据仍然有限。需要更多的研究来解决这些知识差距,以便更好地管理HIV/HBV合并感染患者的HDV合并感染。
Limited data exist on the prevalence, determinants, and outcomes of hepatitis delta virus (HDV) infection among HIV/hepatitis B virus (HBV)-coinfected persons. This review provides current evidence on the epidemiology, natural history, and treatment of HDV infection in patients with HIV/HBV coinfection and highlights future research needs. Cross-sectional studies in Europe, Africa, South America, and Asia show that the prevalence of HDV among HIV/HBV-coinfected patients ranges from 1.2%–25%. No studies have evaluated the prevalence of HDV infection among HIV/HBV-coinfected patients in the United States. HDV infection increases the risk of hepatic decompensation and hepatocellular carcinoma among HIV/HBV-coinfected patients. HDV treatment remains limited to pegylated interferon-alpha, which results in sustained virologic response in <25%. Data on the epidemiology, natural history, and treatment of HDV among HIV/HBV-coinfected persons remain limited. More research is needed to address these knowledge gaps in order to better manage HDV coinfection in HIV/HBV-coinfected patients.
DOI: 10.1016/j.jhep.2016.10.007
发表时间: 2017-02-01
影响因子: 25.7
作者:
Beguelin, Charles;Moradpour, Darius;Wandeler, Gilles
通讯作者: Wandeler, Gilles
DOI: 10.1016/s2468-1253(17)30288-1
发表时间: 2017-12-01
影响因子: 35.7
作者:
Bazinet, Michel;Pantea, Victor;Vaillant, Andrew
通讯作者: Vaillant, Andrew
DOI: 10.3851/imp2728
发表时间: 2014-01-01
期刊: ANTIVIRAL THERAPY
影响因子: 1.2
作者:
Abbas, Zaigham;Memon, Mohammad S.;Hamid, Saeed
通讯作者: Hamid, Saeed
DOI: 10.1089/aid.2013.0008
发表时间: 2013-12-01
影响因子: 1.5
作者:
Boyd, Anders;Miailhes, Patrick;Lacombe, Karine
通讯作者: Lacombe, Karine
DOI: 10.1111/j.1478-3231.2006.01279.x
发表时间: 2006-09-01
影响因子: 6.7
作者:
Erhardt, Andreas;Gerlich, Wolfram;Haeussinger, Dieter
通讯作者: Haeussinger, Dieter